HEADER HYDROLASE/HYDROLASE INHIBITOR 03-JAN-03 1NKK TITLE COMPLEX STRUCTURE OF HCMV PROTEASE AND A PEPTIDOMIMETIC INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: CAPSID PROTEIN P40; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: ASSEMBLIN; COMPND 5 SYNONYM: PROTEASE, CAPSID ASSEMBLY PROTEIN; COMPND 6 EC: 3.4.21.97; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: PEPTIDOMIMETIC INHIBITOR; COMPND 11 CHAIN: E, F, G, H; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN HERPESVIRUS 5; SOURCE 3 ORGANISM_COMMON: HUMAN CYTOMEGALOVIRUS; SOURCE 4 ORGANISM_TAXID: 10359; SOURCE 5 GENE: UL80 OR APNG; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 OTHER_DETAILS: RESIDUE PEPTIDE OF THE PEPTIDOMIMETIC INHIBITOR WAS SOURCE 11 CHEMICALLY SYNTHESIZED. KEYWDS PROTEASE, PEPTIDOMIMETIC INHIBITOR, INDUCED-FIT, HYDROLASE-HYDROLASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR R.KHAYAT,R.BATRA,C.QIAN,T.HALMOS,M.BAILEY,L.TONG REVDAT 4 27-OCT-21 1NKK 1 SEQADV LINK REVDAT 3 13-JUL-11 1NKK 1 VERSN REVDAT 2 24-FEB-09 1NKK 1 VERSN REVDAT 1 11-FEB-03 1NKK 0 JRNL AUTH R.KHAYAT,R.BATRA,C.QIAN,T.HALMOS,M.BAILEY,L.TONG JRNL TITL STRUCTURAL AND BIOCHEMICAL STUDIES OF INHIBITOR BINDING TO JRNL TITL 2 HUMAN CYTOMEGALOVIRUS PROTEASE JRNL REF BIOCHEMISTRY V. 42 885 2003 JRNL REFN ISSN 0006-2960 JRNL PMID 12549906 JRNL DOI 10.1021/BI027045S REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.98 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 797979.900 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 82.6 REMARK 3 NUMBER OF REFLECTIONS : 30941 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.233 REMARK 3 FREE R VALUE : 0.280 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2179 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.76 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 70.90 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4058 REMARK 3 BIN R VALUE (WORKING SET) : 0.3140 REMARK 3 BIN FREE R VALUE : 0.3660 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 6.90 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 299 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.021 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7182 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 249 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 18.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 17.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.44000 REMARK 3 B22 (A**2) : -1.86000 REMARK 3 B33 (A**2) : 1.42000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.34 REMARK 3 ESD FROM SIGMAA (A) : 0.47 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.42 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.54 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.20 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.950 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.250 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.190 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.630 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.570 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.35 REMARK 3 BSOL : 29.95 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : PARAM.HCMV REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : TOP.HCMV REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1NKK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-FEB-03. REMARK 100 THE DEPOSITION ID IS D_1000017952. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-APR-02 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97799 REMARK 200 MONOCHROMATOR : DIAMOND REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : CUSTOM-MADE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38225 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 82.1 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: COMO REMARK 200 SOFTWARE USED: COMO REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.37 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.58 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 4000, HEPES, EDTA, SODIUM REMARK 280 CHLORIDE, SODIUM SULFATE, DTT, SPERMINE_HCL, GLYCEROL, PH 7.0, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 52.58500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 107.62500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 52.58500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 107.62500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5510 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19390 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -14.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5430 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19400 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -18.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D, G, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE N-ACETYL-L-VALYL-3,3-DIMETHYL-L-ALPHA-ASPARTYL-N~4~,N~4~- REMARK 400 DIMETHYL-N~1~-[(1R)-3,3,3-TRIFLUORO-1-METHYL-2-OXOPROPYL]-L- REMARK 400 ASPARTAMIDE IS PEPTIDE-LIKE, A MEMBER OF INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: N-ACETYL-L-VALYL-3,3-DIMETHYL-L-ALPHA-ASPARTYL-N~4~,N~4~- REMARK 400 DIMETHYL-N~1~-[(1R)-3,3,3-TRIFLUORO-1-METHYL-2-OXOPROPYL]-L- REMARK 400 ASPARTAMIDE REMARK 400 CHAIN: E, F, G, H REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 THR A 2 REMARK 465 MET A 3 REMARK 465 GLY A 47 REMARK 465 GLN A 48 REMARK 465 GLY A 49 REMARK 465 GLN A 50 REMARK 465 PRO A 51 REMARK 465 SER A 52 REMARK 465 LEU A 53 REMARK 465 SER A 54 REMARK 465 CYS A 138 REMARK 465 ASP A 139 REMARK 465 ASP A 140 REMARK 465 VAL A 141 REMARK 465 GLU A 142 REMARK 465 GLN A 143 REMARK 465 ALA A 144 REMARK 465 THR A 145 REMARK 465 SER A 146 REMARK 465 LEU A 147 REMARK 465 SER A 148 REMARK 465 GLY A 149 REMARK 465 SER A 150 REMARK 465 GLU A 151 REMARK 465 CYS A 202 REMARK 465 GLY A 203 REMARK 465 SER A 204 REMARK 465 THR A 205 REMARK 465 ALA A 206 REMARK 465 VAL A 207 REMARK 465 ASP A 208 REMARK 465 ALA A 209 REMARK 465 SER A 210 REMARK 465 MET B 301 REMARK 465 THR B 302 REMARK 465 MET B 303 REMARK 465 ASP B 304 REMARK 465 GLY B 347 REMARK 465 GLN B 348 REMARK 465 GLY B 349 REMARK 465 GLN B 350 REMARK 465 PRO B 351 REMARK 465 SER B 352 REMARK 465 LEU B 353 REMARK 465 SER B 354 REMARK 465 ASP B 440 REMARK 465 VAL B 441 REMARK 465 GLU B 442 REMARK 465 GLN B 443 REMARK 465 ALA B 444 REMARK 465 THR B 445 REMARK 465 SER B 446 REMARK 465 LEU B 447 REMARK 465 SER B 448 REMARK 465 GLY B 449 REMARK 465 SER B 450 REMARK 465 SER B 504 REMARK 465 THR B 505 REMARK 465 ALA B 506 REMARK 465 VAL B 507 REMARK 465 ASP B 508 REMARK 465 ALA B 509 REMARK 465 SER B 510 REMARK 465 MET C 1001 REMARK 465 THR C 1002 REMARK 465 MET C 1003 REMARK 465 ASP C 1004 REMARK 465 GLU C 1005 REMARK 465 GLY C 1047 REMARK 465 GLN C 1048 REMARK 465 GLY C 1049 REMARK 465 GLN C 1050 REMARK 465 PRO C 1051 REMARK 465 SER C 1052 REMARK 465 LEU C 1053 REMARK 465 SER C 1054 REMARK 465 GLU C 1142 REMARK 465 GLN C 1143 REMARK 465 ALA C 1144 REMARK 465 THR C 1145 REMARK 465 SER C 1146 REMARK 465 LEU C 1147 REMARK 465 SER C 1148 REMARK 465 GLY C 1149 REMARK 465 SER C 1150 REMARK 465 GLY C 1203 REMARK 465 SER C 1204 REMARK 465 THR C 1205 REMARK 465 ALA C 1206 REMARK 465 VAL C 1207 REMARK 465 ASP C 1208 REMARK 465 ALA C 1209 REMARK 465 SER C 1210 REMARK 465 MET D 1301 REMARK 465 THR D 1302 REMARK 465 MET D 1303 REMARK 465 GLY D 1347 REMARK 465 GLN D 1348 REMARK 465 GLY D 1349 REMARK 465 GLN D 1350 REMARK 465 PRO D 1351 REMARK 465 SER D 1352 REMARK 465 LEU D 1353 REMARK 465 SER D 1354 REMARK 465 CYS D 1438 REMARK 465 ASP D 1439 REMARK 465 ASP D 1440 REMARK 465 VAL D 1441 REMARK 465 GLU D 1442 REMARK 465 GLN D 1443 REMARK 465 ALA D 1444 REMARK 465 THR D 1445 REMARK 465 SER D 1446 REMARK 465 LEU D 1447 REMARK 465 SER D 1448 REMARK 465 GLY D 1449 REMARK 465 SER D 1450 REMARK 465 GLU D 1451 REMARK 465 THR D 1452 REMARK 465 ARG D 1501 REMARK 465 CYS D 1502 REMARK 465 GLY D 1503 REMARK 465 SER D 1504 REMARK 465 THR D 1505 REMARK 465 ALA D 1506 REMARK 465 VAL D 1507 REMARK 465 ASP D 1508 REMARK 465 ALA D 1509 REMARK 465 SER D 1510 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU B 451 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 ALA E 264 C ALA E 264 O 0.155 REMARK 500 ALA F 564 C ALA F 564 O 0.169 REMARK 500 ALA G1264 C ALA G1264 O 0.155 REMARK 500 ALA H1564 C ALA H1564 O 0.163 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 34 79.44 -169.67 REMARK 500 ALA A 67 51.85 -103.09 REMARK 500 VAL A 112 -157.65 -83.34 REMARK 500 SER A 113 -111.04 0.80 REMARK 500 TYR A 128 67.94 -119.12 REMARK 500 VAL A 163 140.75 -178.87 REMARK 500 THR A 169 39.34 -89.76 REMARK 500 ASP A 212 102.82 32.67 REMARK 500 ARG A 215 31.95 -93.11 REMARK 500 PRO B 327 176.39 -54.39 REMARK 500 LEU B 334 82.13 -165.11 REMARK 500 SER B 390 109.85 -45.77 REMARK 500 SER B 413 -101.52 6.89 REMARK 500 TYR B 428 69.80 -114.28 REMARK 500 VAL B 463 122.16 -177.63 REMARK 500 THR B 469 30.59 -85.96 REMARK 500 GLN B 498 -74.07 -63.15 REMARK 500 LEU C1034 79.33 -169.16 REMARK 500 PRO C1111 -166.85 -78.20 REMARK 500 SER C1113 -98.24 20.25 REMARK 500 TYR C1128 72.91 -109.44 REMARK 500 CYS C1138 105.48 -42.91 REMARK 500 ASP C1139 75.82 -177.03 REMARK 500 ASP C1140 75.70 -168.17 REMARK 500 THR C1152 10.07 81.18 REMARK 500 THR C1153 74.00 72.56 REMARK 500 THR C1169 30.51 -93.33 REMARK 500 ASP C1212 104.80 -48.72 REMARK 500 LEU D1334 78.17 -173.09 REMARK 500 ASN D1360 -167.40 -119.94 REMARK 500 HIS D1363 19.82 54.03 REMARK 500 ALA D1367 52.81 -106.87 REMARK 500 SER D1413 -103.05 0.91 REMARK 500 ASP D1512 110.25 -23.59 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN E OF PEPTIDOMIMETIC REMARK 800 INHIBITOR REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN F OF PEPTIDOMIMETIC REMARK 800 INHIBITOR REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN G OF PEPTIDOMIMETIC REMARK 800 INHIBITOR REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN H OF PEPTIDOMIMETIC REMARK 800 INHIBITOR REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2WPO RELATED DB: PDB REMARK 900 RELATED ID: 1NJT RELATED DB: PDB REMARK 900 RELATED ID: 1NJU RELATED DB: PDB REMARK 900 RELATED ID: 1NKM RELATED DB: PDB DBREF 1NKK A 1 256 UNP P16753 VP40_HCMVA 1 256 DBREF 1NKK B 301 556 UNP P16753 VP40_HCMVA 1 256 DBREF 1NKK C 1001 1256 UNP P16753 VP40_HCMVA 1 256 DBREF 1NKK D 1301 1556 UNP P16753 VP40_HCMVA 1 256 DBREF 1NKK E 260 265 PDB 1NKK 1NKK 260 265 DBREF 1NKK F 560 565 PDB 1NKK 1NKK 560 565 DBREF 1NKK G 1260 1265 PDB 1NKK 1NKK 1260 1265 DBREF 1NKK H 1560 1565 PDB 1NKK 1NKK 1560 1565 SEQADV 1NKK ARG A 31 UNP P16753 GLU 31 ENGINEERED MUTATION SEQADV 1NKK GLN A 143 UNP P16753 ALA 143 ENGINEERED MUTATION SEQADV 1NKK ARG B 331 UNP P16753 GLU 31 ENGINEERED MUTATION SEQADV 1NKK GLN B 443 UNP P16753 ALA 143 ENGINEERED MUTATION SEQADV 1NKK ARG C 1031 UNP P16753 GLU 31 ENGINEERED MUTATION SEQADV 1NKK GLN C 1143 UNP P16753 ALA 143 ENGINEERED MUTATION SEQADV 1NKK ARG D 1331 UNP P16753 GLU 31 ENGINEERED MUTATION SEQADV 1NKK GLN D 1443 UNP P16753 ALA 143 ENGINEERED MUTATION SEQRES 1 A 256 MET THR MET ASP GLU GLN GLN SER GLN ALA VAL ALA PRO SEQRES 2 A 256 VAL TYR VAL GLY GLY PHE LEU ALA ARG TYR ASP GLN SER SEQRES 3 A 256 PRO ASP GLU ALA ARG LEU LEU LEU PRO ARG ASP VAL VAL SEQRES 4 A 256 GLU HIS TRP LEU HIS ALA GLN GLY GLN GLY GLN PRO SER SEQRES 5 A 256 LEU SER VAL ALA LEU PRO LEU ASN ILE ASN HIS ASP ASP SEQRES 6 A 256 THR ALA VAL VAL GLY HIS VAL ALA ALA MET GLN SER VAL SEQRES 7 A 256 ARG ASP GLY LEU PHE CYS LEU GLY CYS VAL THR SER PRO SEQRES 8 A 256 ARG PHE LEU GLU ILE VAL ARG ARG ALA SER GLU LYS SER SEQRES 9 A 256 GLU LEU VAL SER ARG GLY PRO VAL SER PRO LEU GLN PRO SEQRES 10 A 256 ASP LYS VAL VAL GLU PHE LEU SER GLY SER TYR ALA GLY SEQRES 11 A 256 LEU SER LEU SER SER ARG ARG CYS ASP ASP VAL GLU GLN SEQRES 12 A 256 ALA THR SER LEU SER GLY SER GLU THR THR PRO PHE LYS SEQRES 13 A 256 HIS VAL ALA LEU CYS SER VAL GLY ARG ARG ARG GLY THR SEQRES 14 A 256 LEU ALA VAL TYR GLY ARG ASP PRO GLU TRP VAL THR GLN SEQRES 15 A 256 ARG PHE PRO ASP LEU THR ALA ALA ASP ARG ASP GLY LEU SEQRES 16 A 256 ARG ALA GLN TRP GLN ARG CYS GLY SER THR ALA VAL ASP SEQRES 17 A 256 ALA SER GLY ASP PRO PHE ARG SER ASP SER TYR GLY LEU SEQRES 18 A 256 LEU GLY ASN SER VAL ASP ALA LEU TYR ILE ARG GLU ARG SEQRES 19 A 256 LEU PRO LYS LEU ARG TYR ASP LYS GLN LEU VAL GLY VAL SEQRES 20 A 256 THR GLU ARG GLU SER TYR VAL LYS ALA SEQRES 1 B 256 MET THR MET ASP GLU GLN GLN SER GLN ALA VAL ALA PRO SEQRES 2 B 256 VAL TYR VAL GLY GLY PHE LEU ALA ARG TYR ASP GLN SER SEQRES 3 B 256 PRO ASP GLU ALA ARG LEU LEU LEU PRO ARG ASP VAL VAL SEQRES 4 B 256 GLU HIS TRP LEU HIS ALA GLN GLY GLN GLY GLN PRO SER SEQRES 5 B 256 LEU SER VAL ALA LEU PRO LEU ASN ILE ASN HIS ASP ASP SEQRES 6 B 256 THR ALA VAL VAL GLY HIS VAL ALA ALA MET GLN SER VAL SEQRES 7 B 256 ARG ASP GLY LEU PHE CYS LEU GLY CYS VAL THR SER PRO SEQRES 8 B 256 ARG PHE LEU GLU ILE VAL ARG ARG ALA SER GLU LYS SER SEQRES 9 B 256 GLU LEU VAL SER ARG GLY PRO VAL SER PRO LEU GLN PRO SEQRES 10 B 256 ASP LYS VAL VAL GLU PHE LEU SER GLY SER TYR ALA GLY SEQRES 11 B 256 LEU SER LEU SER SER ARG ARG CYS ASP ASP VAL GLU GLN SEQRES 12 B 256 ALA THR SER LEU SER GLY SER GLU THR THR PRO PHE LYS SEQRES 13 B 256 HIS VAL ALA LEU CYS SER VAL GLY ARG ARG ARG GLY THR SEQRES 14 B 256 LEU ALA VAL TYR GLY ARG ASP PRO GLU TRP VAL THR GLN SEQRES 15 B 256 ARG PHE PRO ASP LEU THR ALA ALA ASP ARG ASP GLY LEU SEQRES 16 B 256 ARG ALA GLN TRP GLN ARG CYS GLY SER THR ALA VAL ASP SEQRES 17 B 256 ALA SER GLY ASP PRO PHE ARG SER ASP SER TYR GLY LEU SEQRES 18 B 256 LEU GLY ASN SER VAL ASP ALA LEU TYR ILE ARG GLU ARG SEQRES 19 B 256 LEU PRO LYS LEU ARG TYR ASP LYS GLN LEU VAL GLY VAL SEQRES 20 B 256 THR GLU ARG GLU SER TYR VAL LYS ALA SEQRES 1 C 256 MET THR MET ASP GLU GLN GLN SER GLN ALA VAL ALA PRO SEQRES 2 C 256 VAL TYR VAL GLY GLY PHE LEU ALA ARG TYR ASP GLN SER SEQRES 3 C 256 PRO ASP GLU ALA ARG LEU LEU LEU PRO ARG ASP VAL VAL SEQRES 4 C 256 GLU HIS TRP LEU HIS ALA GLN GLY GLN GLY GLN PRO SER SEQRES 5 C 256 LEU SER VAL ALA LEU PRO LEU ASN ILE ASN HIS ASP ASP SEQRES 6 C 256 THR ALA VAL VAL GLY HIS VAL ALA ALA MET GLN SER VAL SEQRES 7 C 256 ARG ASP GLY LEU PHE CYS LEU GLY CYS VAL THR SER PRO SEQRES 8 C 256 ARG PHE LEU GLU ILE VAL ARG ARG ALA SER GLU LYS SER SEQRES 9 C 256 GLU LEU VAL SER ARG GLY PRO VAL SER PRO LEU GLN PRO SEQRES 10 C 256 ASP LYS VAL VAL GLU PHE LEU SER GLY SER TYR ALA GLY SEQRES 11 C 256 LEU SER LEU SER SER ARG ARG CYS ASP ASP VAL GLU GLN SEQRES 12 C 256 ALA THR SER LEU SER GLY SER GLU THR THR PRO PHE LYS SEQRES 13 C 256 HIS VAL ALA LEU CYS SER VAL GLY ARG ARG ARG GLY THR SEQRES 14 C 256 LEU ALA VAL TYR GLY ARG ASP PRO GLU TRP VAL THR GLN SEQRES 15 C 256 ARG PHE PRO ASP LEU THR ALA ALA ASP ARG ASP GLY LEU SEQRES 16 C 256 ARG ALA GLN TRP GLN ARG CYS GLY SER THR ALA VAL ASP SEQRES 17 C 256 ALA SER GLY ASP PRO PHE ARG SER ASP SER TYR GLY LEU SEQRES 18 C 256 LEU GLY ASN SER VAL ASP ALA LEU TYR ILE ARG GLU ARG SEQRES 19 C 256 LEU PRO LYS LEU ARG TYR ASP LYS GLN LEU VAL GLY VAL SEQRES 20 C 256 THR GLU ARG GLU SER TYR VAL LYS ALA SEQRES 1 D 256 MET THR MET ASP GLU GLN GLN SER GLN ALA VAL ALA PRO SEQRES 2 D 256 VAL TYR VAL GLY GLY PHE LEU ALA ARG TYR ASP GLN SER SEQRES 3 D 256 PRO ASP GLU ALA ARG LEU LEU LEU PRO ARG ASP VAL VAL SEQRES 4 D 256 GLU HIS TRP LEU HIS ALA GLN GLY GLN GLY GLN PRO SER SEQRES 5 D 256 LEU SER VAL ALA LEU PRO LEU ASN ILE ASN HIS ASP ASP SEQRES 6 D 256 THR ALA VAL VAL GLY HIS VAL ALA ALA MET GLN SER VAL SEQRES 7 D 256 ARG ASP GLY LEU PHE CYS LEU GLY CYS VAL THR SER PRO SEQRES 8 D 256 ARG PHE LEU GLU ILE VAL ARG ARG ALA SER GLU LYS SER SEQRES 9 D 256 GLU LEU VAL SER ARG GLY PRO VAL SER PRO LEU GLN PRO SEQRES 10 D 256 ASP LYS VAL VAL GLU PHE LEU SER GLY SER TYR ALA GLY SEQRES 11 D 256 LEU SER LEU SER SER ARG ARG CYS ASP ASP VAL GLU GLN SEQRES 12 D 256 ALA THR SER LEU SER GLY SER GLU THR THR PRO PHE LYS SEQRES 13 D 256 HIS VAL ALA LEU CYS SER VAL GLY ARG ARG ARG GLY THR SEQRES 14 D 256 LEU ALA VAL TYR GLY ARG ASP PRO GLU TRP VAL THR GLN SEQRES 15 D 256 ARG PHE PRO ASP LEU THR ALA ALA ASP ARG ASP GLY LEU SEQRES 16 D 256 ARG ALA GLN TRP GLN ARG CYS GLY SER THR ALA VAL ASP SEQRES 17 D 256 ALA SER GLY ASP PRO PHE ARG SER ASP SER TYR GLY LEU SEQRES 18 D 256 LEU GLY ASN SER VAL ASP ALA LEU TYR ILE ARG GLU ARG SEQRES 19 D 256 LEU PRO LYS LEU ARG TYR ASP LYS GLN LEU VAL GLY VAL SEQRES 20 D 256 THR GLU ARG GLU SER TYR VAL LYS ALA SEQRES 1 E 6 ACE VAL DMK DMH ALA CFT SEQRES 1 F 6 ACE VAL DMK DMH ALA CFT SEQRES 1 G 6 ACE VAL DMK DMH ALA CFT SEQRES 1 H 6 ACE VAL DMK DMH ALA CFT MODRES 1NKK DMK E 262 ASP 3,3-DIMETHYL ASPARTIC ACID MODRES 1NKK DMH E 263 ASN N4,N4-DIMETHYL-ASPARAGINE MODRES 1NKK DMK F 562 ASP 3,3-DIMETHYL ASPARTIC ACID MODRES 1NKK DMH F 563 ASN N4,N4-DIMETHYL-ASPARAGINE MODRES 1NKK DMK G 1262 ASP 3,3-DIMETHYL ASPARTIC ACID MODRES 1NKK DMH G 1263 ASN N4,N4-DIMETHYL-ASPARAGINE MODRES 1NKK DMK H 1562 ASP 3,3-DIMETHYL ASPARTIC ACID MODRES 1NKK DMH H 1563 ASN N4,N4-DIMETHYL-ASPARAGINE HET ACE E 260 3 HET DMK E 262 10 HET DMH E 263 10 HET CFT E 265 4 HET ACE F 560 3 HET DMK F 562 10 HET DMH F 563 10 HET CFT F 565 4 HET ACE G1260 3 HET DMK G1262 10 HET DMH G1263 10 HET CFT G1265 4 HET ACE H1560 3 HET DMK H1562 10 HET DMH H1563 10 HET CFT H1565 4 HETNAM ACE ACETYL GROUP HETNAM DMK 3,3-DIMETHYL ASPARTIC ACID HETNAM DMH N4,N4-DIMETHYL-ASPARAGINE HETNAM CFT TRIFLUOROMETHANE FORMUL 5 ACE 4(C2 H4 O) FORMUL 5 DMK 4(C6 H11 N O4) FORMUL 5 DMH 4(C6 H12 N2 O3) FORMUL 5 CFT 4(C H F3) FORMUL 9 HOH *249(H2 O) HELIX 1 1 GLU A 29 LEU A 33 5 5 HELIX 2 2 PRO A 35 GLN A 46 1 12 HELIX 3 3 SER A 90 GLU A 102 1 13 HELIX 4 4 SER A 104 ARG A 109 1 6 HELIX 5 5 ASP A 118 TYR A 128 1 11 HELIX 6 6 ASP A 176 GLN A 182 1 7 HELIX 7 7 THR A 188 ARG A 201 1 14 HELIX 8 8 ASP A 217 TYR A 230 1 14 HELIX 9 9 GLU A 233 VAL A 245 1 13 HELIX 10 10 GLY A 246 ARG A 250 5 5 HELIX 11 11 GLU B 329 LEU B 333 5 5 HELIX 12 12 PRO B 335 GLN B 346 1 12 HELIX 13 13 SER B 390 GLU B 402 1 13 HELIX 14 14 SER B 404 ARG B 409 1 6 HELIX 15 15 ASP B 418 TYR B 428 1 11 HELIX 16 16 ASP B 476 GLN B 482 1 7 HELIX 17 17 THR B 488 GLY B 503 1 16 HELIX 18 18 ASP B 517 TYR B 530 1 14 HELIX 19 19 GLU B 533 VAL B 545 1 13 HELIX 20 20 GLN C 1006 VAL C 1011 1 6 HELIX 21 21 GLU C 1029 LEU C 1033 5 5 HELIX 22 22 PRO C 1035 GLN C 1046 1 12 HELIX 23 23 SER C 1090 LYS C 1103 1 14 HELIX 24 24 SER C 1104 ARG C 1109 1 6 HELIX 25 25 ASP C 1118 TYR C 1128 1 11 HELIX 26 26 ASP C 1176 GLN C 1182 1 7 HELIX 27 27 THR C 1188 GLN C 1200 1 13 HELIX 28 28 ASP C 1217 LEU C 1229 1 13 HELIX 29 29 GLU C 1233 VAL C 1245 1 13 HELIX 30 30 GLU D 1329 LEU D 1333 5 5 HELIX 31 31 PRO D 1335 ALA D 1345 1 11 HELIX 32 32 SER D 1390 GLU D 1402 1 13 HELIX 33 33 SER D 1404 ARG D 1409 1 6 HELIX 34 34 ASP D 1418 TYR D 1428 1 11 HELIX 35 35 ASP D 1476 GLN D 1482 1 7 HELIX 36 36 THR D 1488 GLN D 1500 1 13 HELIX 37 37 ASP D 1517 TYR D 1530 1 14 HELIX 38 38 GLU D 1533 GLY D 1546 1 14 SHEET 1 A 8 VAL A 172 GLY A 174 0 SHEET 2 A 8 VAL A 14 ARG A 22 -1 N GLY A 17 O VAL A 172 SHEET 3 A 8 GLY A 81 VAL A 88 -1 O GLY A 86 N VAL A 16 SHEET 4 A 8 ASP A 64 VAL A 78 -1 N VAL A 78 O GLY A 81 SHEET 5 A 8 PRO A 58 ILE A 61 -1 N LEU A 59 O VAL A 69 SHEET 6 A 8 PHE A 155 CYS A 161 1 O LEU A 160 N ASN A 60 SHEET 7 A 8 GLY A 130 SER A 135 -1 N GLY A 130 O CYS A 161 SHEET 8 A 8 DMK E 262 DMH E 263 -1 O DMK E 262 N SER A 135 SHEET 1 B 8 VAL B 472 GLY B 474 0 SHEET 2 B 8 VAL B 314 ARG B 322 -1 N TYR B 315 O GLY B 474 SHEET 3 B 8 GLY B 381 VAL B 388 -1 O GLY B 386 N VAL B 316 SHEET 4 B 8 VAL B 368 VAL B 378 -1 N ALA B 374 O LEU B 385 SHEET 5 B 8 PRO B 358 ILE B 361 -1 N LEU B 359 O VAL B 369 SHEET 6 B 8 PHE B 455 CYS B 461 1 O LEU B 460 N ASN B 360 SHEET 7 B 8 GLY B 430 SER B 435 -1 N SER B 434 O LYS B 456 SHEET 8 B 8 DMK F 562 DMH F 563 -1 O DMK F 562 N SER B 435 SHEET 1 C 8 VAL C1172 GLY C1174 0 SHEET 2 C 8 VAL C1014 ARG C1022 -1 N GLY C1017 O VAL C1172 SHEET 3 C 8 GLY C1081 VAL C1088 -1 O VAL C1088 N VAL C1014 SHEET 4 C 8 VAL C1068 VAL C1078 -1 N ALA C1074 O LEU C1085 SHEET 5 C 8 PRO C1058 ILE C1061 -1 N LEU C1059 O GLY C1070 SHEET 6 C 8 PHE C1155 CYS C1161 1 O LEU C1160 N ASN C1060 SHEET 7 C 8 GLY C1130 SER C1135 -1 N GLY C1130 O CYS C1161 SHEET 8 C 8 DMK G1262 DMH G1263 -1 O DMK G1262 N SER C1135 SHEET 1 D 8 VAL D1472 GLY D1474 0 SHEET 2 D 8 VAL D1314 ARG D1322 -1 N GLY D1317 O VAL D1472 SHEET 3 D 8 GLY D1381 VAL D1388 -1 O GLY D1386 N VAL D1316 SHEET 4 D 8 ASP D1364 VAL D1378 -1 N HIS D1371 O CYS D1387 SHEET 5 D 8 PRO D1358 ILE D1361 -1 N LEU D1359 O VAL D1369 SHEET 6 D 8 PHE D1455 CYS D1461 1 O LEU D1460 N ASN D1360 SHEET 7 D 8 GLY D1430 SER D1435 -1 N GLY D1430 O CYS D1461 SHEET 8 D 8 DMK H1562 DMH H1563 -1 O DMK H1562 N SER D1435 LINK OG SER A 132 C ALA E 264 1555 1555 1.44 LINK OG SER B 432 C ALA F 564 1555 1555 1.45 LINK OG SER C1132 C ALA G1264 1555 1555 1.45 LINK OG SER D1432 C ALA H1564 1555 1555 1.44 LINK C ACE E 260 N VAL E 261 1555 1555 1.33 LINK C VAL E 261 N DMK E 262 1555 1555 1.33 LINK C DMK E 262 N DMH E 263 1555 1555 1.33 LINK C DMH E 263 N ALA E 264 1555 1555 1.33 LINK C ALA E 264 C1 CFT E 265 1555 1555 1.55 LINK C ACE F 560 N VAL F 561 1555 1555 1.32 LINK C VAL F 561 N DMK F 562 1555 1555 1.33 LINK C DMK F 562 N DMH F 563 1555 1555 1.33 LINK C DMH F 563 N ALA F 564 1555 1555 1.34 LINK C ALA F 564 C1 CFT F 565 1555 1555 1.56 LINK C ACE G1260 N VAL G1261 1555 1555 1.33 LINK C VAL G1261 N DMK G1262 1555 1555 1.33 LINK C DMK G1262 N DMH G1263 1555 1555 1.33 LINK C DMH G1263 N ALA G1264 1555 1555 1.34 LINK C ALA G1264 C1 CFT G1265 1555 1555 1.56 LINK C ACE H1560 N VAL H1561 1555 1555 1.33 LINK C VAL H1561 N DMK H1562 1555 1555 1.33 LINK C DMK H1562 N DMH H1563 1555 1555 1.33 LINK C DMH H1563 N ALA H1564 1555 1555 1.33 LINK C ALA H1564 C1 CFT H1565 1555 1555 1.56 SITE 1 AC1 14 ARG A 31 HIS A 63 SER A 132 LEU A 133 SITE 2 AC1 14 SER A 134 SER A 135 ARG A 136 ARG A 137 SITE 3 AC1 14 CYS A 161 GLY A 164 ARG A 165 HOH A2051 SITE 4 AC1 14 HOH A2246 HOH E2138 SITE 1 AC2 15 ARG B 331 HIS B 363 SER B 432 LEU B 433 SITE 2 AC2 15 SER B 434 SER B 435 ARG B 436 ARG B 437 SITE 3 AC2 15 VAL B 463 GLY B 464 ARG B 465 ARG B 466 SITE 4 AC2 15 HOH B2092 HOH F2022 HOH F2109 SITE 1 AC3 14 ARG C1031 HIS C1063 SER C1132 LEU C1133 SITE 2 AC3 14 SER C1134 SER C1135 ARG C1136 ARG C1137 SITE 3 AC3 14 CYS C1161 GLY C1164 ARG C1165 HOH C2098 SITE 4 AC3 14 HOH C2127 HOH G2073 SITE 1 AC4 16 ARG D1331 HIS D1363 LEU D1431 SER D1432 SITE 2 AC4 16 LEU D1433 SER D1434 SER D1435 ARG D1436 SITE 3 AC4 16 ARG D1437 GLY D1464 ARG D1465 ARG D1466 SITE 4 AC4 16 HOH D2052 HOH D2057 HOH D2234 HOH H2151 CRYST1 105.170 215.250 52.330 90.00 90.00 90.00 P 21 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009508 0.000000 0.000000 0.00000 SCALE2 0.000000 0.004646 0.000000 0.00000 SCALE3 0.000000 0.000000 0.019109 0.00000 MASTER 490 0 16 38 32 0 16 6 0 0 0 84 END